annual cash & cash equivalents:
$171.32M+$86.10M(+101.03%)Summary
- As of today (May 29, 2025), RDY annual cash & cash equivalents is $171.32 million, with the most recent change of +$86.10 million (+101.03%) on March 1, 2025.
- During the last 3 years, RDY annual cash & cash equivalents has fallen by -$24.55 million (-12.53%).
- RDY annual cash & cash equivalents is now -59.09% below its all-time high of $418.74 million, reached on March 31, 2007.
Performance
RDY Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$171.32M+$28.07M(+19.59%)Summary
- As of today (May 29, 2025), RDY quarterly cash & cash equivalents is $171.32 million, with the most recent change of +$28.07 million (+19.59%) on March 1, 2025.
- Over the past year, RDY quarterly cash & cash equivalents has increased by +$86.10 million (+101.03%).
- RDY quarterly cash & cash equivalents is now -59.09% below its all-time high of $418.74 million, reached on March 31, 2007.
Performance
RDY quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
RDY Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +101.0% | +101.0% |
| 3 y3 years | -12.5% | -12.5% |
| 5 y5 years | +529.4% | +529.4% |
RDY Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -12.5% | +143.4% | -12.5% | +191.0% |
| 5 y | 5-year | -15.1% | +529.4% | -42.0% | +529.4% |
| alltime | all time | -59.1% | +1559.5% | -59.1% | +599.9% |
RDY Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | $171.32M(+101.0%) | $171.32M(+19.6%) |
| Dec 2024 | - | $143.25M(+5.8%) |
| Sep 2024 | - | $135.34M(+129.9%) |
| Jun 2024 | - | $58.87M(-30.9%) |
| Mar 2024 | $85.22M(+21.1%) | $85.22M(-3.1%) |
| Dec 2023 | - | $87.95M(-45.4%) |
| Sep 2023 | - | $160.93M(+119.5%) |
| Jun 2023 | - | $73.31M(+4.2%) |
| Mar 2023 | $70.39M(-64.1%) | $70.39M(-6.9%) |
| Dec 2022 | - | $75.63M(-32.3%) |
| Sep 2022 | - | $111.64M(+46.4%) |
| Jun 2022 | - | $76.27M(-61.1%) |
| Mar 2022 | $195.87M(-3.0%) | $195.87M(-33.7%) |
| Dec 2021 | - | $295.25M(+119.9%) |
| Sep 2021 | - | $134.28M(+22.1%) |
| Jun 2021 | - | $109.95M(-45.5%) |
| Mar 2021 | $201.90M(+641.7%) | $201.90M(+243.2%) |
| Dec 2020 | - | $58.83M(+12.1%) |
| Sep 2020 | - | $52.49M(-9.6%) |
| Jun 2020 | - | $58.09M(+113.4%) |
| Mar 2020 | $27.22M(-15.2%) | $27.22M(-13.2%) |
| Dec 2019 | - | $31.36M(-26.6%) |
| Sep 2019 | - | $42.71M(+43.3%) |
| Jun 2019 | - | $29.81M(-7.1%) |
| Mar 2019 | $32.08M(-20.8%) | $32.08M(+31.1%) |
| Dec 2018 | - | $24.48M(-53.0%) |
| Sep 2018 | - | $52.12M(+63.7%) |
| Jun 2018 | - | $31.85M(-21.4%) |
| Mar 2018 | $40.52M(-32.0%) | $40.52M(+28.7%) |
| Dec 2017 | - | $31.48M(-16.4%) |
| Sep 2017 | - | $37.64M(-13.7%) |
| Jun 2017 | - | $43.59M(-26.9%) |
| Mar 2017 | $59.61M(-19.6%) | $59.61M(-32.8%) |
| Dec 2016 | - | $88.78M(+142.9%) |
| Sep 2016 | - | $36.55M(-61.1%) |
| Jun 2016 | - | $93.93M(+26.7%) |
| Mar 2016 | $74.11M(-14.1%) | $74.11M(-16.5%) |
| Dec 2015 | - | $88.78M(-12.4%) |
| Sep 2015 | - | $101.35M(+2.6%) |
| Jun 2015 | - | $98.78M(+14.5%) |
| Mar 2015 | $86.25M(-38.9%) | $86.25M(-12.9%) |
| Dec 2014 | - | $99.00M(-25.8%) |
| Sep 2014 | - | $133.43M(+23.1%) |
| Jun 2014 | - | $108.39M(-23.2%) |
| Mar 2014 | $141.22M(+49.6%) | $141.22M(-58.9%) |
| Dec 2013 | - | $343.58M(+87.7%) |
| Sep 2013 | - | $183.07M(+21.4%) |
| Jun 2013 | - | $150.77M(+59.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2013 | $94.40M(-34.3%) | $94.40M(-41.1%) |
| Dec 2012 | - | $160.36M(+21.8%) |
| Sep 2012 | - | $131.62M(-11.7%) |
| Jun 2012 | - | $149.00M(+3.7%) |
| Mar 2012 | $143.67M(+12.0%) | $143.67M(-54.1%) |
| Dec 2011 | - | $312.66M(+101.3%) |
| Sep 2011 | - | $155.34M(+27.3%) |
| Jun 2011 | - | $121.99M(-4.9%) |
| Mar 2011 | $128.33M(-12.6%) | $128.33M(+39.5%) |
| Dec 2010 | - | $92.01M(-33.6%) |
| Sep 2010 | - | $138.48M(+1.1%) |
| Jun 2010 | - | $137.00M(-6.7%) |
| Mar 2010 | $146.76M(+32.9%) | $146.76M(+23.0%) |
| Dec 2009 | - | $119.31M(-7.2%) |
| Sep 2009 | - | $128.51M(-0.8%) |
| Jun 2009 | - | $129.49M(+17.3%) |
| Mar 2009 | $110.41M(-40.3%) | $110.41M(+40.3%) |
| Dec 2008 | - | $78.67M(-28.6%) |
| Sep 2008 | - | $110.14M(+27.4%) |
| Jun 2008 | - | $86.47M(-53.3%) |
| Mar 2008 | $185.01M(-55.8%) | $185.01M(+16.2%) |
| Dec 2007 | - | $159.26M(-25.2%) |
| Sep 2007 | - | $212.99M(-22.3%) |
| Jun 2007 | - | $274.19M(-34.5%) |
| Mar 2007 | $418.74M(+400.9%) | $418.74M(+10.8%) |
| Dec 2006 | - | $377.89M(+255.5%) |
| Sep 2006 | - | $106.29M(+41.4%) |
| Jun 2006 | - | $75.17M(-10.1%) |
| Mar 2006 | $83.59M(-60.8%) | $83.59M(-53.8%) |
| Dec 2005 | - | $180.99M(-24.7%) |
| Sep 2005 | - | $240.51M(+0.9%) |
| Jun 2005 | - | $238.47M(+12.0%) |
| Mar 2005 | $212.98M(+110.4%) | $212.98M(+61.7%) |
| Dec 2004 | - | $131.74M(+9.0%) |
| Sep 2004 | - | $120.83M(+34.1%) |
| Jun 2004 | - | $90.07M(-11.0%) |
| Mar 2004 | $101.21M(-32.5%) | $101.21M(-20.3%) |
| Dec 2003 | - | $126.97M(-23.8%) |
| Sep 2003 | - | $166.55M(+0.8%) |
| Jun 2003 | - | $165.25M(+10.2%) |
| Mar 2003 | $149.96M(+43.2%) | $149.96M(+4.3%) |
| Dec 2002 | - | $143.74M(+7.0%) |
| Sep 2002 | - | $134.28M(+3.8%) |
| Jun 2002 | - | $129.32M(+23.5%) |
| Mar 2002 | $104.70M(+914.2%) | $104.70M(+26.0%) |
| Dec 2001 | - | $83.08M(+29.6%) |
| Sep 2001 | - | $64.11M(-4.5%) |
| Jun 2001 | - | $67.15M |
| Mar 2001 | $10.32M | - |
FAQ
- What is Dr Reddys Laboratories Limited annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Dr Reddys Laboratories Limited?
- What is Dr Reddys Laboratories Limited annual cash & cash equivalents year-on-year change?
- What is Dr Reddys Laboratories Limited quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Dr Reddys Laboratories Limited?
- What is Dr Reddys Laboratories Limited quarterly cash & cash equivalents year-on-year change?
What is Dr Reddys Laboratories Limited annual cash & cash equivalents?
The current annual cash & cash equivalents of RDY is $171.32M
What is the all time high annual cash & cash equivalents for Dr Reddys Laboratories Limited?
Dr Reddys Laboratories Limited all-time high annual cash & cash equivalents is $418.74M
What is Dr Reddys Laboratories Limited annual cash & cash equivalents year-on-year change?
Over the past year, RDY annual cash & cash equivalents has changed by +$86.10M (+101.03%)
What is Dr Reddys Laboratories Limited quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of RDY is $171.32M
What is the all time high quarterly cash & cash equivalents for Dr Reddys Laboratories Limited?
Dr Reddys Laboratories Limited all-time high quarterly cash & cash equivalents is $418.74M
What is Dr Reddys Laboratories Limited quarterly cash & cash equivalents year-on-year change?
Over the past year, RDY quarterly cash & cash equivalents has changed by +$86.10M (+101.03%)